Literature DB >> 17145383

Dupuytren's diathesis revisited: Evaluation of prognostic indicators for risk of disease recurrence.

Sandip Hindocha1, John K Stanley, Stewart Watson, Ardeshir Bayat.   

Abstract

PURPOSE: The term diathesis relates to certain features of Dupuytren's disease (DD) and dictates an aggressive course of disease. The initial description of DD diathesis included 4 factors: (1) ethnicity, (2) family history, (3) bilateral DD, and (4) ectopic lesions (DD outside the palm). The degree of diathesis is considered important in predicting recurrence and extension of DD after surgical management. Prognostic indicators of risks associated with surgery are important. We aimed to evaluate these 4 factors and known associated risk factors to formulate a statistical predictive value for DD diathesis.
METHODS: Caucasian patients diagnosed with DD between the ages of 25 and 90 years (n = 322) from Northwest England were assessed for DD diathesis with a clinical history and examination. DD diathesis assessment was analyzed by calculating the odds ratios of developing recurrent DD using logistic regression.
RESULTS: The observed recurrence rates in the presence of notable risk factors and corresponding odds ratios of recurrent DD were calculated. Of note, recurrent disease was observed in 121 (46%) males, 105 (47%) with bilateral DD, 68 (48%) with a family history of DD, 75 (47%) with age at onset younger than 50 years, 35 (52%) in those with ectopic lesions, and in 26 (63%) with Garrod's pads.
CONCLUSIONS: The original DD diathesis factors have been evaluated and modified. The original factors of family history, bilateral DD, and ectopic lesions now include 2 additional factors: male gender and age at onset of younger than 50 years. Family history and ectopic disease have now been modified to specify family history with one or more affected siblings/parents and ectopic lesions in the knuckles (Garrod's pads) alone. The presence of all new DD diathesis factors in a patient increases the risk of recurrent DD by 71% compared with a baseline risk of 23% in those DD patients with none of the earlier-described factors. TYPE OF STUDY/LEVEL OF EVIDENCE: Prognostic II.

Entities:  

Mesh:

Year:  2006        PMID: 17145383     DOI: 10.1016/j.jhsa.2006.09.006

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  31 in total

1.  Connective tissue diseases: Unpicking Dupruyten disease etiology-is Wnt the way?

Authors:  Ardeshir Bayat
Journal:  Nat Rev Rheumatol       Date:  2011-11-15       Impact factor: 20.543

2.  Aggressive Dupuytren's diathesis in a young woman.

Authors:  Ivan Couto-Gonzalez; Beatriz Brea-Garcia; Antonio Taboada-Suárez; Eduardo González-Álvarez
Journal:  BMJ Case Rep       Date:  2010-09-20

3.  Connective tissue diseases: A nonsurgical therapy for Dupuytren disease.

Authors:  Ardeshir Bayat
Journal:  Nat Rev Rheumatol       Date:  2010-01       Impact factor: 20.543

4.  Revised Tubiana's staging system for assessment of disease severity in Dupuytren's disease-preliminary clinical findings.

Authors:  Sandip Hindocha; John K Stanley; James Stewart Watson; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2007-09-11

5.  Surgical complications associated with fasciectomy for dupuytren's disease: a 20-year review of the English literature.

Authors:  Keith Denkler
Journal:  Eplasty       Date:  2010-01-27

Review 6.  [Epidemiology of Dupuytren's disease].

Authors:  P Hahn
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

7.  Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence.

Authors:  Ilse Degreef; Luc De Smet; Raf Sciot; Jean-Jacques Cassiman; Sabine Tejpar
Journal:  Clin Orthop Relat Res       Date:  2008-10-29       Impact factor: 4.176

8.  Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology.

Authors:  Sandip Hindocha; Duncan Angus McGrouther; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2009-01-15

9.  Molecular mechanisms and treatment strategies for Dupuytren's disease.

Authors:  David B O'Gorman; Linda Vi; Bing Siang Gan
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

10.  Type-1 Collagen differentially alters beta-catenin accumulation in primary Dupuytren's Disease cord and adjacent palmar fascia cells.

Authors:  Linda Vi; Anna Njarlangattil; Yan Wu; Bing Siang Gan; David B O'Gorman
Journal:  BMC Musculoskelet Disord       Date:  2009-06-19       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.